Wei Yankai, Li Na, Zhao Lu, Yang Chao, Ma Binyun, Li Xiaorong, Wei Ruihua, Nian Hong
Tianjin Key Laboratory of Retinal Functions and Diseases, Tianjin International Joint Research and Development Centre of Ophthalmology and Vision Science, Eye Institute and School of Optometry, Tianjin Medical University Eye Hospital, Tianjin, China.
Department of Medicine/Hematology, Keck School of Medicine of the University of Southern California, Los Angeles, CA, United States.
Front Cell Dev Biol. 2020 Aug 20;8:818. doi: 10.3389/fcell.2020.00818. eCollection 2020.
MicroRNAs (miRNAs) are evolutionarily conserved short non-coding RNAs that act at post-transcriptional regulation of gene expression by destroying target messenger RNA or inhibiting its translation. Recently, miRNAs have been identified as important regulators in autoimmunity. Aberrant expression and function of miRNAs can lead to dysfunction of immune system and mediate autoimmune disorders. Here, we summarize the roles of miRNAs that have been implicated in three representative ocular autoimmune disorders, including autoimmune uveitis, Grave's ophthalmopathy, and Sjögren's syndrome dry eye, and discuss the potential of miRNAs as biomarkers and therapeutic targets for the diagnosis and treatment of these diseases.
微小RNA(miRNA)是进化上保守的短链非编码RNA,通过破坏靶信使RNA或抑制其翻译来在转录后水平调控基因表达。最近,miRNA已被确定为自身免疫中的重要调节因子。miRNA的异常表达和功能可导致免疫系统功能障碍并介导自身免疫性疾病。在此,我们总结了miRNA在三种代表性眼部自身免疫性疾病中的作用,包括自身免疫性葡萄膜炎、格雷夫斯眼病和干燥综合征干眼症,并讨论了miRNA作为这些疾病诊断和治疗的生物标志物及治疗靶点的潜力。